Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 24973713)

1.

Alterations of GABAergic and dopaminergic systems in mutant mice with disruption of exons 2 and 3 of the Disc1 gene.

Nakai T, Nagai T, Wang R, Yamada S, Kuroda K, Kaibuchi K, Yamada K.

Neurochem Int. 2014 Jul;74:74-83. doi: 10.1016/j.neuint.2014.06.009. Epub 2014 Jun 26.

PMID:
24973713
2.

Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse.

Kuroda K, Yamada S, Tanaka M, Iizuka M, Yano H, Mori D, Tsuboi D, Nishioka T, Namba T, Iizuka Y, Kubota S, Nagai T, Ibi D, Wang R, Enomoto A, Isotani-Sakakibara M, Asai N, Kimura K, Kiyonari H, Abe T, Mizoguchi A, Sokabe M, Takahashi M, Yamada K, Kaibuchi K.

Hum Mol Genet. 2011 Dec 1;20(23):4666-83. doi: 10.1093/hmg/ddr400. Epub 2011 Sep 8.

3.

Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants.

Sakae N, Yamasaki N, Kitaichi K, Fukuda T, Yamada M, Yoshikawa H, Hiranita T, Tatsumi Y, Kira J, Yamamoto T, Miyakawa T, Nakayama KI.

Hum Mol Genet. 2008 Oct 15;17(20):3191-203. doi: 10.1093/hmg/ddn215. Epub 2008 Jul 22.

4.

Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice.

Lee FH, Zai CC, Cordes SP, Roder JC, Wong AH.

Mol Brain. 2013 Apr 30;6:20. doi: 10.1186/1756-6606-6-20.

5.

Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia.

Lipina TV, Niwa M, Jaaro-Peled H, Fletcher PJ, Seeman P, Sawa A, Roder JC.

Genes Brain Behav. 2010 Oct;9(7):777-89. doi: 10.1111/j.1601-183X.2010.00615.x. Epub 2010 Aug 12.

PMID:
20618446
6.

Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders.

Ayhan Y, Abazyan B, Nomura J, Kim R, Ladenheim B, Krasnova IN, Sawa A, Margolis RL, Cadet JL, Mori S, Vogel MW, Ross CA, Pletnikov MV.

Mol Psychiatry. 2011 Mar;16(3):293-306. doi: 10.1038/mp.2009.144. Epub 2010 Jan 5.

7.

Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model.

Pogorelov VM, Nomura J, Kim J, Kannan G, Ayhan Y, Yang C, Taniguchi Y, Abazyan B, Valentine H, Krasnova IN, Kamiya A, Cadet JL, Wong DF, Pletnikov MV.

Neuropharmacology. 2012 Mar;62(3):1242-51. doi: 10.1016/j.neuropharm.2011.02.003. Epub 2011 Feb 17.

8.

Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors.

Günther U, Benson J, Benke D, Fritschy JM, Reyes G, Knoflach F, Crestani F, Aguzzi A, Arigoni M, Lang Y, et al.

Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7749-53.

9.

Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.

Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG.

J Neurosci. 1998 Jul 1;18(13):4861-9.

10.

DBZ (DISC1-binding zinc finger protein)-deficient mice display abnormalities in basket cells in the somatosensory cortices.

Koyama Y, Hattori T, Shimizu S, Taniguchi M, Yamada K, Takamura H, Kumamoto N, Matsuzaki S, Ito A, Katayama T, Tohyama M.

J Chem Neuroanat. 2013 Nov;53:1-10. doi: 10.1016/j.jchemneu.2013.07.002. Epub 2013 Aug 2.

PMID:
23912123
11.

GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.

Sibille E, Morris HM, Kota RS, Lewis DA.

Int J Neuropsychopharmacol. 2011 Jul;14(6):721-34. doi: 10.1017/S1461145710001616.

12.

Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes.

Eagleson KL, Gravielle MC, Schlueter McFadyen-Ketchum LJ, Russek SJ, Farb DH, Levitt P.

Neuroscience. 2010 Jul 14;168(3):797-810. doi: 10.1016/j.neuroscience.2010.03.066. Epub 2010 Apr 7.

13.

Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission.

Karayannis T, Au E, Patel JC, Kruglikov I, Markx S, Delorme R, Héron D, Salomon D, Glessner J, Restituito S, Gordon A, Rodriguez-Murillo L, Roy NC, Gogos JA, Rudy B, Rice ME, Karayiorgou M, Hakonarson H, Keren B, Huguet G, Bourgeron T, Hoeffer C, Tsien RW, Peles E, Fishell G.

Nature. 2014 Jul 10;511(7508):236-40.

14.

Block of voltage-gated calcium channels stimulates dopamine efflux in rat mesocorticolimbic system.

Belardetti F, Ahn S, So K, Snutch TP, Phillips AG.

Neuropharmacology. 2009 May-Jun;56(6-7):984-93. doi: 10.1016/j.neuropharm.2009.02.001. Epub 2009 Feb 11.

PMID:
19371580
15.

Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.

Nakajima A, Yamada K, Nagai T, Uchiyama T, Miyamoto Y, Mamiya T, He J, Nitta A, Mizuno M, Tran MH, Seto A, Yoshimura M, Kitaichi K, Hasegawa T, Saito K, Yamada Y, Seishima M, Sekikawa K, Kim HC, Nabeshima T.

J Neurosci. 2004 Mar 3;24(9):2212-25.

16.

Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons.

Centonze D, Grande C, Usiello A, Gubellini P, Erbs E, Martin AB, Pisani A, Tognazzi N, Bernardi G, Moratalla R, Borrelli E, Calabresi P.

J Neurosci. 2003 Jul 16;23(15):6245-54.

17.

In vivo neurochemical evidence that newly synthesised GABA activates GABA(B), but not GABA(A), receptors on dopaminergic nerve endings in the nucleus accumbens of freely moving rats.

Saigusa T, Aono Y, Sekino R, Uchida T, Takada K, Oi Y, Koshikawa N, Cools AR.

Neuropharmacology. 2012 Feb;62(2):907-13. doi: 10.1016/j.neuropharm.2011.09.021. Epub 2011 Sep 28.

PMID:
21964521
18.

Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia.

Curley AA, Eggan SM, Lazarus MS, Huang ZJ, Volk DW, Lewis DA.

Neurobiol Dis. 2013 Feb;50:179-86. doi: 10.1016/j.nbd.2012.10.018. Epub 2012 Oct 26.

19.

Novel δ1-receptor agonist KNT-127 increases the release of dopamine and L-glutamate in the striatum, nucleus accumbens and median pre-frontal cortex.

Tanahashi S, Ueda Y, Nakajima A, Yamamura S, Nagase H, Okada M.

Neuropharmacology. 2012 Apr;62(5-6):2057-67. doi: 10.1016/j.neuropharm.2012.01.005. Epub 2012 Jan 17.

PMID:
22266218
20.

Hyperactivity and cortical disinhibition in mice with restricted expression of mutant huntingtin to parvalbumin-positive cells.

Dougherty SE, Hollimon JJ, McMeekin LJ, Bohannon AS, West AB, Lesort M, Hablitz JJ, Cowell RM.

Neurobiol Dis. 2014 Feb;62:160-71. doi: 10.1016/j.nbd.2013.10.002. Epub 2013 Oct 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk